Clinical Trial Update: Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Massachusetts General Hospital evaluating ketamine's effects on neuronal molecular signatures and the brain connectome in depression…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidality

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression, Suicide | Phase 1 | Status: NOT_YET_RECRUITING